- Home
- EMBC vs CRON Comparison
EMBC vs CRON Comparison
Compare EMBC & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMBC
- CRON
- Stock Information
- Founded
- EMBC 1924
- CRON N/A
- Country
- EMBC United States
- CRON Canada
- Employees
- EMBC N/A
- CRON N/A
- Industry
- EMBC Medical/Dental Instruments
- CRON Medicinal Chemicals and Botanical Products
- Sector
- EMBC Health Care
- CRON Health Care
- Exchange
- EMBC Nasdaq
- CRON Nasdaq
- Market Cap
- EMBC 788.4M
- CRON 809.4M
- IPO Year
- EMBC N/A
- CRON N/A
- Fundamental
- Price
- EMBC $15.15
- CRON $2.58
- Analyst Decision
- EMBC Buy
- CRON
- Analyst Count
- EMBC 2
- CRON 0
- Target Price
- EMBC $18.50
- CRON N/A
- AVG Volume (30 Days)
- EMBC 488.5K
- CRON 2.9M
- Earning Date
- EMBC 08-08-2025
- CRON 11-11-2025
- Dividend Yield
- EMBC 3.98%
- CRON N/A
- EPS Growth
- EMBC 18.26
- CRON N/A
- EPS
- EMBC 1.42
- CRON 0.05
- Revenue
- EMBC $1,102,500,000.00
- CRON $130,282,000.00
- Revenue This Year
- EMBC N/A
- CRON $19.67
- Revenue Next Year
- EMBC N/A
- CRON $30.56
- P/E Ratio
- EMBC $10.62
- CRON $53.48
- Revenue Growth
- EMBC N/A
- CRON 28.01
- 52 Week Low
- EMBC $9.20
- CRON $1.60
- 52 Week High
- EMBC $21.48
- CRON $2.77
- Technical
- Relative Strength Index (RSI)
- EMBC 65.65
- CRON 59.40
- Support Level
- EMBC $14.92
- CRON $2.50
- Resistance Level
- EMBC $15.44
- CRON $2.63
- Average True Range (ATR)
- EMBC 0.52
- CRON 0.10
- MACD
- EMBC -0.08
- CRON -0.01
- Stochastic Oscillator
- EMBC 72.11
- CRON 52.63
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
About CRON Cronos Group Inc. Common Share
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.